Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types (Q34899382)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 17, 2011

edit

Language	Label	Description	Also known as
English	Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types	scientific article published on March 17, 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

title

Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types (English)

1 reference

stated in

Crossref

DOI

10.1158/0008-5472.CAN-10-3471

reference URL

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-3471

retrieved

27 November 2024

main subject

metformin

1 reference

based on heuristic

inferred from title

xenograft

1 reference

based on heuristic

inferred from title

chemotherapy

1 reference

based on heuristic

inferred from title

author name string

Dimitrios Iliopoulos

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

Kevin Struhl

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

Heather A. Hirsch

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21415163

retrieved

27 November 2024

language of work or name

English

0 references

publication date

17 March 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

full work available at URL

https://aacrjournals.org/cancerres/article-pdf/71/9/3196/2667213/3196.pdf

file format

Portable Document Format

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21415163

retrieved

27 November 2024

https://europepmc.org/articles/PMC3085572

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21415163

retrieved

27 November 2024

https://europepmc.org/articles/PMC3085572?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21415163

retrieved

27 November 2024

https://doi.org/10.1158/0008-5472.can-10-3471

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21415163

retrieved

27 November 2024

https://aacrjournals.org/cancerres/article-pdf/71/9/3196/2667213/3196.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1158/0008-5472.CAN-10-3471

reference URL

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-3471

retrieved

27 November 2024

published in

Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

volume

71

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

page(s)

3196-3201

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

cites work

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Update in hematology and oncology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metabolic syndrome, hyperinsulinemia, and cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Cancer stem cells in solid tumors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Molecular definition of breast tumor heterogeneity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Metformin and reduced risk of cancer in diabetic patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

8 July 2018

Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

26 October 2018

Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

26 October 2018

Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085572

retrieved

26 October 2018

Identifiers

DOI

10.1158/0008-5472.CAN-10-3471

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

Fatcat ID

release_xsb5ekrwszelpnf4z2u3tc6mpa

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/xsb5ekrwszelpnf4z2u3tc6mpa

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

3085572

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

PubMed publication ID

21415163

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21415163

retrieved

5 August 2017

ResearchGate publication ID

50419947

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34899382&oldid=2281717480"